BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 7755658)

  • 1. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH; Watts GF; Umpleby M; Hennessy TR; Quiney JR; Sönksen PH
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H; Ninnis R; Miserez AR; Baumstark MW; Keller U
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simvastatin decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: pathophysiological and therapeutic implications.
    Watts GF; Cummings MH; Umpleby M; Quiney JR; Naoumova R; Thompson GR; Sönksen PH
    Eur J Clin Invest; 1995 Aug; 25(8):559-67. PubMed ID: 7589011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Int J Obes Relat Metab Disord; 1998 May; 22(5):414-23. PubMed ID: 9622338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth hormone treatment on very-low density lipoprotein apolipoprotein B100 turnover in adult hypopituitarism.
    Chrisoulidou A; Kousta E; Venkatesan S; Gray R; Bannister PA; Gallagher JJ; Lawrence N; Johnston DG
    Metabolism; 2000 May; 49(5):563-6. PubMed ID: 10831163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man.
    Riches FM; Watts GF; Naoumova RP; Kelly JM; Croft KD; Thompson GR
    Atherosclerosis; 1997 Nov; 135(1):83-91. PubMed ID: 9395276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects.
    Watts GF; Naoumova R; Cummings MH; Umpleby AM; Slavin BM; Sönksen PH; Thompson GR
    Metabolism; 1995 Aug; 44(8):1052-7. PubMed ID: 7637647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of apolipoprotein B-100 and of triglyceride-rich lipoprotein particles in the absence of functional lipoprotein lipase.
    Pacy PJ; Mitropoulos KA; Venkatesan S; Watts GF; Reeves BE; Halliday D
    Atherosclerosis; 1993 Nov; 103(2):231-43. PubMed ID: 8292098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN; Le NA; Gibson JC
    J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.
    Teng B; Sniderman AD; Soutar AK; Thompson GR
    J Clin Invest; 1986 Mar; 77(3):663-72. PubMed ID: 3949973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesteryl ester storage disease.
    Cummings MH; Watts GF
    Clin Chem; 1995 Jan; 41(1):111-4. PubMed ID: 7813057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia.
    Maugeais C; Ouguerram K; Frénais R; Maugère P; Charbonnel B; Magot T; Krempf M
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1679-86. PubMed ID: 11297603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of evidence for reduced plasma apo B48 catabolism in patients with heterozygous familial hypercholesterolemia carrying the same null LDL receptor gene mutation.
    Tremblay AJ; Lamarche B; Ruel I; Hogue JC; Bergeron J; Gagné C; Couture P
    Atherosclerosis; 2004 Feb; 172(2):367-73. PubMed ID: 15019548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fish oil concentrate on lipoproteins and apolipoproteins in familial combined hyperlipidemia.
    Tatò F; Keller C; Wolfram G
    Clin Investig; 1993 Apr; 71(4):314-8. PubMed ID: 8471818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
    Kissebah AH; Alfarsi S; Adams PW
    Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum low density lipoprotein cholesterol level and cholesterol absorption efficiency are influenced by apolipoprotein B and E polymorphism and by the FH-Helsinki mutation of the low density lipoprotein receptor gene in familial hypercholesterolemia.
    Gylling H; Aalto-Setälä K; Kontula K; Miettinen TA
    Arterioscler Thromb; 1991; 11(5):1368-75. PubMed ID: 1911722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.
    Fisher WR; Zech LA; Stacpoole PW
    Arterioscler Thromb; 1994 Apr; 14(4):501-10. PubMed ID: 8148348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.
    Tremblay AJ; Lamarche B; Ruel IL; Hogue JC; Deshaies Y; Gagné C; Couture P
    Atherosclerosis; 2006 Sep; 188(1):203-12. PubMed ID: 16337207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human triglyceride-rich lipoprotein apo E kinetics and its relationship to LDL apo B-100 metabolism.
    Millar JS; Lichtenstein AH; Ordovas JM; Dolnikowski GG; Schaefer EJ
    Atherosclerosis; 2001 Apr; 155(2):477-85. PubMed ID: 11254920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.